Article Information
History
- April 21, 2022.
Article Versions
- Version 1 (April 20, 2022 - 10:24).
- You are currently viewing Version 2 of this article (April 21, 2022 - 08:49).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Margaret L. Lind1,#,
- Alexander James Robertson1,
- Julio Silva2,
- Frederick Warner3,4,
- Andreas C. Coppi3,4,
- Nathan Price3,4,
- Chelsea Duckwall1,
- Peri Sosensky1,
- Erendira C. Di Giuseppe1,
- Ryan Borg1,
- Mariam O Fofana1,
- Otavio T. Ranzani5,6,
- Natalie E. Dean7,
- Jason R. Andrews8,
- Julio Croda1,9,10,
- Akiko Iwasaski2,11,
- Derek A.T. Cummings12,13,*,
- Albert I. Ko1,14,*,#,
- Matt DT Hitchings15,* and
- Wade L. Schulz16,17,*
- 1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
- 2Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
- 3Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
- 4Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA
- 5Barcelona Institute for Global Health, ISGlobal, Universitat Pompeu Fabra (UPF), Barcelona; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
- 6Pulmonary Division, Heart Institute, Hospital das Clínicas, Faculdade de Medicina, São Paulo, SP, Brazil
- 7Department of Biostatistics & Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA
- 8Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA,USA
- 9Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, MS, Brazil
- 10Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
- 11Howard Hughes Medical Institute, Chevy Chase, MD, USA
- 12Department of Biology, University of Florida, Gainesville, FL, USA
- 13Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA
- 14Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, BA, Brazil
- 15Department of Biostatistics, College of Public Health and Health Professions & College of Medicine, University of Florida, Gainesville, FL, USA
- 16Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
- 17Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, USA
- ↵#Corresponding Author:
Margaret L Lind, PhD, Margaret.Lind{at}yale.edu, Department of Epidemiology of Microbial Diseases, Yale School of Public Health, 60 College St., New Haven, CT 06510, Albert I Ko, MD, Albert.Ko{at}yale.edu, Department of Epidemiology of Microbial Diseases, Yale School of Public Health, 60 College St., New Haven, CT 06510
↵* Equal Senior Author Contribution
Posted April 21, 2022.
Effectiveness of Primary and Booster COVID-19 mRNA Vaccination against Infection Caused by the SARS-CoV-2 Omicron Variant in People with a Prior SARS-CoV-2 Infection
